Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
RENB Stock Forecast 2025-2026
$0.32
Current Price
$54.03M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to RENB Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
RENB Price Momentum
0.0%
1 Week Change
-8.6%
1 Month Change
-67.0%
1 Year Change
-61.9%
Year-to-Date Change
-86.2%
From 52W High of $2.34
+13.0%
From 52W Low of $0.29
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Renovaro (RENB) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on RENB and similar high-potential opportunities.
Latest RENB Stock Price Targets & Analyst Predictions
RENB has shown a year-to-date change of -61.9% and a 1-year change of -67.0%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RENB. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
RENB Analyst Ratings
0
Buy
0
Hold
0
Sell
RENB Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.32
Latest RENB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for RENB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Renovaro Inc. (RENB) Competitors
The following stocks are similar to Renovaro based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Renovaro Inc. (RENB) Financial Data
Renovaro Inc. has a market capitalization of $54.03M with a P/E ratio of -0.4x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -188.5%.
Valuation Metrics
Market Cap
$54.03M
Enterprise Value
$59.68M
P/E Ratio
-0.4x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+0.6%
Current Ratio
0.1x
Debt/Equity
8.8x
ROE
-188.5%
ROA
-18.1%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Renovaro Inc. (RENB) Business Model
About Renovaro Inc.
What They Do
Provides renewable energy solutions and technologies.
Business Model
Renovaro Inc. generates revenue by designing, developing, and implementing renewable energy systems such as solar panels, wind turbines, and energy storage solutions. The company partners with governments, private enterprises, and non-profits to expand access to renewable energy, capitalizing on the increasing global demand for clean energy.
Additional Information
Renovaro Inc. plays a crucial role in the transition to sustainable energy, supporting efforts to reduce carbon emissions and achieve climate goals. Its commitment to environmentally responsible practices positions it as a significant player in the green technology market, driving growth in infrastructure development.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
25
CEO
Mr. David H. Weinstein
Country
United States
IPO Year
2018
Website
renovarogroup.comRenovaro Inc. (RENB) Latest News & Analysis
Latest News
Quick Summary
Renovaro Inc. (NASDAQ: RENB) launched Augusta, a new AI-driven Precision Neurology Platform for drug and biomarker discovery, aiming to enhance outcomes in neurology and cancer treatment.
Why It Matters
Renovaro Inc.'s launch of the Augusta platform could enhance drug discovery in neurology, potentially leading to breakthroughs and increased market value, attracting investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Renovaro Inc. (NASDAQ: RENB) announced an exclusive collaboration with Amsterdam UMC to develop blood platelet RNA diagnostics, advancing clinical validation in disease detection.
Why It Matters
Renovaro Inc.'s collaboration with Amsterdam UMC enhances its R&D capabilities, potentially leading to innovative diagnostic solutions, which could drive stock value and investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Renovaro Inc. (NASDAQ: RENB) is expanding its collaboration with Nebul to enhance early disease detection using AI and high-performance computing, focusing on cancer and neurological conditions.
Why It Matters
Renovaro's partnership with Nebul enhances its AI capabilities for early disease detection, potentially increasing its market value and attractiveness for investors focused on healthcare innovation.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
1 month ago
Quick Summary
Renovaro Biosciences (NASDAQ: RENB) has completed its merger with BioSymetrics, enhancing its AI-driven drug discovery and precision medicine capabilities in cancer and neurology.
Why It Matters
Renovaro's merger with BioSymetrics enhances its AI capabilities in drug development, potentially leading to breakthrough therapies and increased market competitiveness, positively impacting investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Renovaro Biosciences Inc. (NASDAQ: RENB) has announced a merger with Predictive Oncology Inc. (NASDAQ: POAI) to integrate AI/ML technologies and lab capabilities in the US and Europe.
Why It Matters
The merger with Predictive Oncology enhances Renovaro's capabilities in diagnostics and therapies, potentially increasing market share and innovation, influencing stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
2 months ago
Quick Summary
Renovaro Biosciences (NASDAQ: RENB) has initiated financing for integrating AI/ML technologies and lab capabilities with Predictive Oncology (NASDAQ: POAI), enhancing drug discovery and diagnostics in oncology.
Why It Matters
Renovaro's financing for AI integration boosts its drug discovery capabilities, enhancing growth potential in oncology. This strategic move could increase market competitiveness and investor interest.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About RENB Stock
What is Renovaro Inc.'s (RENB) stock forecast for 2025?
Analyst forecasts for Renovaro Inc. (RENB) are not currently available. The stock is trading at $0.32.
Is RENB stock a good investment in 2025?
Analyst ratings for RENB are not currently available. The stock is currently trading at $0.32. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for RENB stock?
Price predictions from Wall Street analysts for RENB are not currently available. The stock is trading at $0.32.
What is Renovaro Inc.'s business model?
Renovaro Inc. generates revenue by designing, developing, and implementing renewable energy systems such as solar panels, wind turbines, and energy storage solutions. The company partners with governments, private enterprises, and non-profits to expand access to renewable energy, capitalizing on the increasing global demand for clean energy.
What is the highest forecasted price for RENB Renovaro Inc.?
Price targets from Wall Street analysts for RENB are not currently available. The stock is trading at $0.32.
What is the lowest forecasted price for RENB Renovaro Inc.?
Price targets from Wall Street analysts for RENB are not currently available. The stock is trading at $0.32.
What is the overall RENB consensus from analysts for Renovaro Inc.?
Analyst ratings for RENB are not currently available. The stock is trading at $0.32.
How accurate are RENB stock price projections?
Stock price projections, including those for Renovaro Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 10:02 AM UTC